| Bassam I Hasan, MD | |
|
2125 Route 88 E, Brick, NJ 08724-3273 | |
| (732) 892-4548 | |
| (732) 892-0961 |
| Full Name | Bassam I Hasan |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 43 Years |
| Location | 2125 Route 88 E, Brick, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346246097 | NPI | - | NPPES |
| 6404707 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | MA058494 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hackensack Meridian Health At Home Ocean County | Brick, NJ | Home health agency |
| Ocean Medical Center | Brick, NJ | Hospital |
| Jfk Medical Center | Edison, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ocean County Family Care, P.a. | 6800881673 | 4 |
News Archive
It is an accepted fact that genetics play a key role in a person's susceptibility to cancer, and that throughout life, mutations can cause damage to tumor suppressor genes further increasing the chances of developing cancerous tumors.
A collaborative team of researchers spearheaded by Dennis Carson M.D., professor of medicine and director of the Rebecca and John Moores UCSD Cancer Center at the University of California, San Diego (UCSD) has identified a potent new anti-cancer drug isolated from a toxic blue-green algae found in the South Pacific.
STEMCELL Technologies has announced the schedule for their fall training program. This includes 2-day courses on mesenchymal stem cell biology (October 2nd and 3rd), mammary stem cell biology (October 17th and 18th), neural stem cell biology (October 30th and 31st), hematopoietic stem cell biology (October 30th and 31st), and human embryonic and induced pluripotent stem cell biology (November 14th and 15th).
Researchers at the University of Toronto examined fungi in the mucus of patients with cystic fibrosis and discovered how one particularly cunning fungal species has evolved to defend itself against neighbouring bacteria.
According to a new market report published by Transparency Market Research Heparin Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2022" the Heparin Market Europe was valued at USD 2,004.5 million in 2013 and is estimated to reach USD 3,148.0 million by 2022 growing with a CAGR of 5.2% from 2014 to 2022.
› Verified 4 days ago
| Entity Name | Ocean County Family Care, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821019787 PECOS PAC ID: 6800881673 Enrollment ID: O20040420000335 |
News Archive
It is an accepted fact that genetics play a key role in a person's susceptibility to cancer, and that throughout life, mutations can cause damage to tumor suppressor genes further increasing the chances of developing cancerous tumors.
A collaborative team of researchers spearheaded by Dennis Carson M.D., professor of medicine and director of the Rebecca and John Moores UCSD Cancer Center at the University of California, San Diego (UCSD) has identified a potent new anti-cancer drug isolated from a toxic blue-green algae found in the South Pacific.
STEMCELL Technologies has announced the schedule for their fall training program. This includes 2-day courses on mesenchymal stem cell biology (October 2nd and 3rd), mammary stem cell biology (October 17th and 18th), neural stem cell biology (October 30th and 31st), hematopoietic stem cell biology (October 30th and 31st), and human embryonic and induced pluripotent stem cell biology (November 14th and 15th).
Researchers at the University of Toronto examined fungi in the mucus of patients with cystic fibrosis and discovered how one particularly cunning fungal species has evolved to defend itself against neighbouring bacteria.
According to a new market report published by Transparency Market Research Heparin Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2022" the Heparin Market Europe was valued at USD 2,004.5 million in 2013 and is estimated to reach USD 3,148.0 million by 2022 growing with a CAGR of 5.2% from 2014 to 2022.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bassam I Hasan, MD 2290 W County Line Rd, Jackson, NJ 08527-2267 Ph: (732) 942-4455 | Bassam I Hasan, MD 2125 Route 88 E, Brick, NJ 08724-3273 Ph: (732) 892-4548 |
News Archive
It is an accepted fact that genetics play a key role in a person's susceptibility to cancer, and that throughout life, mutations can cause damage to tumor suppressor genes further increasing the chances of developing cancerous tumors.
A collaborative team of researchers spearheaded by Dennis Carson M.D., professor of medicine and director of the Rebecca and John Moores UCSD Cancer Center at the University of California, San Diego (UCSD) has identified a potent new anti-cancer drug isolated from a toxic blue-green algae found in the South Pacific.
STEMCELL Technologies has announced the schedule for their fall training program. This includes 2-day courses on mesenchymal stem cell biology (October 2nd and 3rd), mammary stem cell biology (October 17th and 18th), neural stem cell biology (October 30th and 31st), hematopoietic stem cell biology (October 30th and 31st), and human embryonic and induced pluripotent stem cell biology (November 14th and 15th).
Researchers at the University of Toronto examined fungi in the mucus of patients with cystic fibrosis and discovered how one particularly cunning fungal species has evolved to defend itself against neighbouring bacteria.
According to a new market report published by Transparency Market Research Heparin Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2022" the Heparin Market Europe was valued at USD 2,004.5 million in 2013 and is estimated to reach USD 3,148.0 million by 2022 growing with a CAGR of 5.2% from 2014 to 2022.
› Verified 4 days ago
Dr. Mrugesh Chhaganlal Panchani, M.D Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 210 Jack Martin Blvd Ste D1, Brick, NJ 08724 Phone: 732-458-5854 Fax: 732-458-8012 | |
Dr. Ladan Ilkhani, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 985 Cedarbridge Ave, Brick, NJ 08723 Phone: 732-477-5600 Fax: 732-477-1899 | |
Dr. Morrow C. Corvasce, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 329 Cedarcroft Dr, Brick, NJ 08724 Phone: 732-892-7749 Fax: 732-701-1447 | |
Dr. Jessica Bautista Seares, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 35 Beaverson Blvd Bldg 7, Suite B, Brick, NJ 08723 Phone: 732-262-2400 Fax: 732-262-3883 | |
Dr. Ariel Meyer, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 210 Jack Martin Blvd., Suite D-1, Brick, NJ 08724 Phone: 732-458-5067 Fax: 732-458-4962 | |
Dr. Ali R Moosvi, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1640 Highway 88, Suite 201, Brick, NJ 08724 Phone: 732-840-1900 Fax: 732-840-0355 | |
Dr. Uchenna Obiageli Orazulike, M.D Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 970 Route 70, Brick, NJ 08724 Phone: 732-836-6020 Fax: 732-836-6001 |